Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol

Anderson Bermon, Ana Fernanda Uribe-Rodríguez, Paula Fernanda Pérez-Rivero, David Prieto-Merino, Diana Isabel Cáceres Rivera, Elizabeth Guio, Louise Atkins, Robert Horne, Elizabeth Murray, Norma Cecilia Serrano Díaz, Caroline Free, Pablo Perel, Juan P Casas, Anderson Bermon, Ana Fernanda Uribe-Rodríguez, Paula Fernanda Pérez-Rivero, David Prieto-Merino, Diana Isabel Cáceres Rivera, Elizabeth Guio, Louise Atkins, Robert Horne, Elizabeth Murray, Norma Cecilia Serrano Díaz, Caroline Free, Pablo Perel, Juan P Casas

Abstract

Introduction: Anti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic cardiovascular diseases (ASCVD) for reducing the risk of ASCVD events. Unfortunately, there is abundant evidence that adherence to these cardiovascular medications is far from ideal. A recent Cochrane review showed a potential beneficial effect of Short Message Service (SMS) interventions on adherence to medication in ASCVD patients.

Methods and analysis: The txt2heart study is a pragmatic randomised single-blind controlled trial. The objective is to evaluate the efficacy and safety of an intervention with SMS messages delivered by mobile phones to improve adherence to cardiovascular medications in patients with ASCVD. The intervention consists of behavioural techniques delivered via SMS. The primary outcome is change in blood serum low-density lipoprotein cholesterol levels as an indicator of adherence to statins. Secondary outcomes will include systolic blood pressure as an indicator of adherence to blood-lowering therapies and heart rate as an indicator of adherence to beta-blockers, urine levels of 11-dehydrothromboxane B2, self-reported adherence to cardiovascular medications and rates of cardiovascular death or hospitalisation due to cardiovascular disease.

Ethics and dissemination: The study will be performed in compliance with the protocol, regulatory requirements, Good Clinical Practice and ethical principles of the Declaration of Helsinki. The Ethics Committee of Fundación Cardiovascular de Colombia evaluated and approved the trial. The txt2heart Colombia trial aims to provide robust evidence to evaluate whether SMS messages delivered through mobile telephones change the behaviour of Colombian patients who have suffered a cardiovascular event. Trial results will be presented to the local health authorities, and if the intervention is effective and safe, we hope this strategy will be implemented quickly because of its low cost and wide-reaching impact on the population.

Trial registration number: NCT03098186.

Keywords: Cardiovascular diseases; Health behavior; Medications adherence; mHealth; text messaging.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Trial flowchart. ASCVD, atherosclerotic cardiovascular diseases; LDL-C, low-density lipoprotein cholesterol; MARS-5, Medication Adherence Report Scale 5; SMS, Short Message Service; 11 dhTxB2, 11-dehydrothromboxaneB2.

References

    1. Perel P, Avezum A, Huffman M, et al. . Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the world heart Federation roadmap for secondary prevention of cardiovascular disease. Glob Heart 2015;10:99–110. 10.1016/j.gheart.2015.04.003
    1. Perel P, Casas JP, Ortiz Z, et al. . Noncommunicable diseases and injuries in Latin America and the Caribbean: time for action. PLoS Med 2006;3:e344 10.1371/journal.pmed.0030344
    1. World Health Organization Model list of essential medicines (20th list), 2017. Available: [Accessed June 23 2017].
    1. Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002;360:2–3. 10.1016/S0140-6736(02)09358-3
    1. Yusuf S, Islam S, Chow CK, et al. . Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the pure study): a prospective epidemiological survey. Lancet 2011;378:1231–43. 10.1016/S0140-6736(11)61215-4
    1. Rashid MA, Edwards D, Walter FM, et al. . Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med 2014;12:224–32. 10.1370/afm.1620
    1. London School of Hygiene and Tropical Medicine Patient factors that influence cardiovascular medication adherence. [Msc]. London: London School of Hygiene and Tropical Medicine, 2014. Available: [Accessed January 2016].
    1. Santo K, Kirkendall S, Laba T-L, et al. . Interventions to improve medication adherence in coronary disease patients: a systematic review and meta-analysis of randomised controlled trials. Eur J Prev Cardiol 2016;23:1065–76. 10.1177/2047487316638501
    1. International Telecommunications Union Ict facts and figures, 2014. Available: [Accessed 20 Jul 2017].
    1. Free C, Phillips G, Galli L, et al. . The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med 2013;10:e1001362 10.1371/journal.pmed.1001362
    1. Catalani C, Philbrick W, Fraser H, et al. . mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature. Open AIDS J 2013;7:17–41. 10.2174/1874613620130812003
    1. Adler AJ, Martin N, Mariani J, et al. . Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017;4 10.1002/14651858.CD011851.pub2
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Abroms LC, Whittaker R, Free C, et al. . Developing and Pretesting a text messaging program for health behavior change: recommended steps. JMIR Mhealth Uhealth 2015;3:e107 10.2196/mhealth.4917
    1. Michie S, Richardson M, Johnston M, et al. . The behavior change technique taxonomy (V1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81–95. 10.1007/s12160-013-9486-6
    1. Moore GF, Audrey S, Barker M, et al. . Process evaluation of complex interventions: medical Research Council guidance. BMJ 2015;350:h1258 10.1136/bmj.h1258
    1. Uribe-Rodríguez A, Pérez-Rivero PF, Free C, et al. . Designing a text messaging program to increase adherence to medication for the secondary prevention of cardiovascular disease. medRxiv 2019:19002683.
    1. Hicks KA, Tcheng JE, Bozkurt B, et al. . 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American heart association Task force on clinical data standards (writing Committee to develop cardiovascular endpoints data standards). Circulation 2015;132:302–61. 10.1161/CIR.0000000000000156
    1. Mahler C, Hermann K, Horne R, et al. . Assessing reported adherence to pharmacological treatment recommendations. translation and evaluation of the medication adherence report scale (MARS) in Germany. J Eval Clin Pract 2010;16:574–9. 10.1111/j.1365-2753.2009.01169.x

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera